PREDICTORS OF PRESENTEEISM AND ABSENTEEISM IN PATIENTS COMMENCING TREATMENT WITH METHOTREXATE MONOTHERAPY OR BIOLOGIC THERAPY FOR RHEUMATOID ARTHRITIS

被引：0
|
作者：
Leggett, Sarah [1 ]
Lunt, Mark [1 ]
Barton, Anne [2 ]
Hyrich, Kimme [1 ]
Walker-Bone, Karen [3 ]
Verstappen, Suzanne [1 ]
机构：
[1] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England
[3] Univ Southampton, Arthrit Res UK MRC Ctr Musculoskeletal Hlth & Wor, Southampton, Hants, England
来源：
RHEUMATOLOGY | 2018年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
227
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Chen, Su
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1566 - 1572
  • [22] Improvement in High Density Lipoprotein Function in Early Rheumatoid Arthritis Patients Treated with Methotrexate Monotherapy or Combination Therapy in the Treatment of Early Rheumatoid Arthritis Trial
    Charles-Schoeman, C.
    Lee, Yuen Yin
    Shahbazian, Ani
    Elashoff, David
    Wong, Xiaoyan
    Curtis, Jeffrey R.
    Navarro-Millan, Iris
    Yang, Shuo
    Chen, Lang
    Cofield, Stacey
    Moreland, Larry W.
    Paulus, Harold E.
    O' Dell, James
    Bathon, Joan M.
    Bridges, S. Louis, Jr.
    Reddy, Srinivasa T.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3321 - 3321
  • [23] Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis
    Qiu, Qi
    Huang, Jing
    Lin, Yang
    Shu, Xiaoming
    Fan, Huizheng
    Tu, Zhihua
    Zhou, Youwen
    Xiao, Cheng
    MEDICINE, 2017, 96 (11)
  • [24] LEUCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS PRESCRIBED METHOTREXATE AS COMBINATION OR MONOTHERAPY
    Reynolds, Neal D.
    Edwards, Mark H.
    Hull, Richard G.
    Ledingham, Joanna M.
    RHEUMATOLOGY, 2009, 48 : I61 - I61
  • [25] Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy
    Graciela S Alarcón
    Nature Clinical Practice Rheumatology, 2006, 2 : 296 - 297
  • [26] Clinical efficacy of combination therapy of prospidin and methotrexate vs monotherapy of methotrexate for rheumatoid arthritis
    Nemtsov, BF
    Simonova, OV
    Politova, NN
    Benenson, EV
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 168 - 168
  • [27] Early rheumatoid arthritis:: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy
    Alarcón, GS
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (06): : 296 - 297
  • [28] Biologic Therapy for Rheumatoid Arthritis Clinical Efficacy and Predictors of Response
    Gibbons, Laura J.
    Hyrich, Kimme L.
    BIODRUGS, 2009, 23 (02) : 111 - 124
  • [29] Efficacy of Methotrexate Monotherapy Compared to Combination Therapy with Methotrexate and Hydroxychloroquine in the Treatment of Early Rheumatoid Arthritis after 12 Months of Treatment
    Dissanayake, Tharindri
    Martin, Liam
    Barr, Susan
    Penney, Christopher
    Morris, Gary
    Mosher, Dianne
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1494 - 1495
  • [30] Predictors of delay in methotrexate treatment in a cohort of rheumatoid arthritis patients referred to hospital
    de Thurah, A.
    Norgaard, M.
    Stengaard-Petersen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 324 - 324
12345